Wednesday, March 20, 2019 10:54:51 AM
https://thegreenfund.com/elixinol-global-seeing-high-profits-from-diverse-investment
The Burning Issue of ODC Approval
Elixinol Global’s pharmaceutical grade medicinal cannabis company—formerly known as Elixinol Pty Ltd—is the NSW-based Nunyara Pharma.
Nunyara is currently developing a state-of-the-art growing facility in Northern NSW and has been left waiting for cannabis license approvals from the Office of Drug Control (ODC) for more than a year.
Once the licenses have been granted the company will begin using its high-tech greenhouses to produce the raw materials needed to manufacture its pre-existing CBD formulations. This will make Nunyara one of the few Australian companies that is capable of cultivating, manufacturing and distributing high-quality cannabis products to the Australian market.
“We’ve had plans for some time now to create a cultivation and manufacturing facility for high-grade medical cannabis in Australia”
– Paul Benhaim, Elixinol CEO
“Now, high-grade medical cannabis in Australia includes CBD and THC, because the government doesn’t differentiate them yet. I think they might wake up to the reality one day, but for the time being, we’re incorporating both of those under the Nunyara name.”
“We have applied for our licenses with the Office of Drug Control, more than one year ago, when the Office stated that they would give us our licenses within twenty days. But we are very hopeful that our licenses will be granted in the not-too-distant future, and have shown this by buying land that is perfectly suited to the medical cannabis division, and the needs of the Australia market.”
Like Hemp Foods Australia, Nunyara’s commercial focus will also be settled squarely on Australia for the time being.
While Nunyara is not opposed to the future exportation of its’ product line, Benhaim confirmed that its’ current focus is on fine-tuning the ideal method to bring the company’s cannabis products to market, as delays from the ODC are preventing it from commencing cultivation activities.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM